Fluvoxamine Impurity 13 | CAS 61747-22-6 - Request Quote
Fluvoxamine Impurity 13
| SZ CAT No: | SZ-F007044 |
| CAS No | 61747-22-6 |
| Mol.F. | C13H16F3NO2 |
| Mol.Wt. |
275.3 |
| Inv. Status |
Under Synthesis |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Fluvoxamine Impurity 13 is chemically (Z)-5-methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one oxime. Fluvoxamine Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Fluvoxamine Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Fluvoxamine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 61747-22-6
Purchase 61747-22-6
Order 61747-22-6
Enquire 61747-22-6
price of 61747-22-6
61747-22-6 Supplier
61747-22-6 Manufacturer
61747-22-6 Exporter
buy high quality Fluvoxamine Impurity 13
Purchase Fluvoxamine Impurity 13
Fluvoxamine Impurity 13 suppliers
Fluvoxamine Impurity 13 manufacturers
Fluvoxamine Impurity 13 price
Order Fluvoxamine Impurity 13
Enquire Fluvoxamine Impurity 13
Fluvoxamine Impurity 13 cost
Fluvoxamine Impurity 13 Supplier
Fluvoxamine Impurity 13 Distributor
Fluvoxamine Impurity 13 for Method Validation
Fluvoxamine Reference Standard
Fluvoxamine Impurity 13 for ANDA Filing
Fluvoxamine Impurity 13 for Forced Degradation Studies
Fluvoxamine Impurity 13 Identification Standards
Fluvoxamine Impurity 13 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.